Published in Am J Kidney Dis on November 19, 2013
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol (1993) 3.83
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med (2003) 2.21
Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int (2007) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant (2012) 1.94
Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2012) 1.88
Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int (2001) 1.84
Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.81
The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant (1998) 1.72
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int (2012) 1.71
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis (2004) 1.69
Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int (2005) 1.67
Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol (2012) 1.67
Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Am J Kidney Dis (2010) 1.63
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol (2003) 1.56
(23)Na magnetic resonance imaging of tissue sodium. Hypertension (2011) 1.29
Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2011) 1.25
Peritoneal dialysis. Am J Kidney Dis (2003) 1.20
Molecular basis for the dialysis disequilibrium syndrome: altered aquaporin and urea transporter expression in the brain. Nephrol Dial Transplant (2005) 1.08
Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int (2002) 1.07
Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest (1992) 1.07
A critical review of sodium profiling for hemodialysis. Semin Dial (2001) 1.05
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant (2008) 1.02
In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis (2000) 0.98
Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol (1993) 0.95
Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial. Blood Purif (2012) 0.95
Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis. Am J Kidney Dis (2008) 0.94
Home hemodialysis, daily hemodialysis, and nocturnal hemodialysis: Core Curriculum 2009. Am J Kidney Dis (2009) 0.94
Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation? Nephrol Dial Transplant (2012) 0.88
Optimizing the dialysate calcium concentration in bicarbonate haemodialysis. Nephrol Dial Transplant (2012) 0.85
Variability in potassium removal by hemodialysis. Am J Nephrol (1986) 0.83
The diffusion gradient between ionized calcium in dialysate and plasma water--corrected for Gibbs-Donnan factor--is the main driving force of net calcium balance during haemodialysis. Nephrol Dial Transplant (2010) 0.80
Water quality in conventional and home haemodialysis. Nat Rev Nephrol (2012) 0.79
Is there any role for sodium modeling in the prevention of intradialytic hypotension in patients with large interdialytic fluid gains? Semin Dial (2011) 0.79
Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. Kidney Int (1987) 0.78
The importance of ultrafiltration on acid-base status in a dialysis population. ASAIO Trans (1989) 0.76